+1 628 258 0071(US) +44
2035 002 764(UK)
Search For Reports
GET FREE SAMPLE R
Home / Reports
/ Diabetic Retinopathy Market
Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample
form for updated data
Diabetic Retinopathy Market is expected to register a CAGR of 11.9% during the forecast period of 2019 to
2025, with a market value of USD 1,309.73 Billion in 2018.
Eye diseases in diabetic patients are known as diabetic retinopathy. High blood sugar levels lead to the damage of the
blood vessels in the retina. This results in the swelling and leakage of blood vessels or the blood vessels may close,
thereby stopping blood from passing through. Sometimes, abnormal growth of new blood vessels is found on the retina.
Blurred vision, dark or empty areas in your vision, spots, or dark strings floating in the vision (floaters), impaired color
vision, and vision loss are various symptoms of diabetic retinopathy.
Vitreous hemorrhage, retinal detachment, glaucoma, and blindness are various complications associated with
diabetic retinopathy, which may further lead to vision loss. The disease can be prevented by managing
diabetes, controlling blood glucose levels, attention to vision changes, and many other methods in order to
avoid vision impairment or vision loss.
The global diabetic retinopathy market is driven by factors such as the rising prevalence of diabetes and the
increasing prevalence of blindness due to diabetes. Additionally, increasing geriatric population and increasing
demand for diagnostic tests for the early diagnosis of diabetic retinopathy are anticipated to fuel the market
growth. On the other hand, the lack of awareness about treatment is projected to hamper the growth of the
market during the assessment period.
Moreover, major companies in the market are involved in strategic acquisitions, collaborations, product
launch, expansion, and